While I support research and innovation, treatments must meet certain scientific and ethical standards before they can be responsibly offered
GLP-1 receptor agonists are primarily recommended for adults who meet specific criteria, including the following 2,5,7 : A body mass index (BMI) of 30 or higher, indicative of obesity A BMI of 27 or higher, categorized as overweight, in individuals with at least 1 weight-related comorbidity such as hypertension, dyslipidemia, or type 2 diabetes Despite their benefits, these medications are contraindicated in certain populations, including those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
The most common include: Nausea Vomiting Diarrhea Constipation These side effects are usually mild and tend to improve over time as your body adjusts to the medication
Prioritise rest Allow your body time to adjust
Clinical data indicates that these changes in appetite can manifest quite early